Illya Kostin, partner and head of intellectual property and dispute resolution practices at Legal Alliance Company, has been named among the leading Life Sciences lawyers in the world according to Who's Who Legal: Life Sciences 2018 independent legal market research. Recognition in 3 nominations – regulatory, patent litigation and transactional – once again confirms professionalism, strong expertise, unique experience and excellent reputation of Illya Kostin and the team in these practices.
The results of comprehensive annual research with peers and clients by the authoritative international guide Who's Who Legal (WWL) was published in April.
This year WWL: Life Sciences 2018 recommends 1047 lawyers from 420 firms all over the world and marks those law firms and lawyers which are the most qualified in their respective regions. In particular, it features 218 transactional lawyers selected for their prominent work in life sciences, those who focus on mergers and acquisitions, IPO, securities and venture capital transactions, outsourcing and investment agreements and joint ventures; 314 regulatory law experts who advise clients and offer innovative solutions on a range of issues, from product development and manufacture to pricing, market safety and customs rules; 399 legal practitioners in the field of patent litigation from across 211 law firms worldwide, experienced at handling patent disputes in various areas including pharmaceuticals, biotechnology and medical devices.
Due to deep niche expertise of our lawyers, Legal Alliance Company for a lot of years has had leading positions among Ukrainian and foreign law firms in the area of Life Sciences, which encompasses such areas of pharmaceuticals, medical products, consumer goods, medicine, veterinary medicine, cosmetics, chemistry, biotechnology, agriculture and food products.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
